XTX Topco Ltd - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 76 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$113,142
-16.0%
20,204
-21.5%
0.01%
-65.5%
Q4 2023$134,678
-43.3%
25,751
+71.1%
0.03%
-29.3%
Q3 2023$237,33915,0500.04%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 121,014$5,377,0001.78%
Smith, Graham & Co., Investment Advisors, LP 232,343$10,323,0001.28%
GLOBEFLEX CAPITAL L P 73,205$3,252,0000.79%
SummerHaven Investment Management, LLC 18,604$827,0000.56%
BRANDES INVESTMENT PARTNERS, LP 464,292$20,628,0000.50%
Capital Impact Advisors, LLC 11,728$521,0000.48%
Watershed Asset Management, L.L.C. 5,756$256,0000.32%
Foundry Partners, LLC 84,325$3,747,0000.23%
Summit Global Investments 33,738$1,499,0000.13%
SCOUT INVESTMENTS, INC. 147,034$6,533,0000.13%
View complete list of EAGLE PHARMACEUTICALS INC shareholders